Just promise you that you won't buy penny stocks unless you are

a) An insider
b) Someone who has done so much research that you know a company inside out.
c) A fortune teller

Haha. What a stressful week. Have a great weekend.

Buy O&G this week. Early invitation

Pandai2 find O&G counters that have the best fundamentals and upside and you will win.

Hope you all accumulate O&G a few days ago as I posted. But need a lot of patience. Need to pick the right counter as well.

Because apparently during the O&G boom, a lot of companies basically mushroomed. So in another words, a lot of crap business in the market. Pick one with the lowest debt to equity ratio and you’re good to go. Good trading opportunities

I hope you did not chase after Amtel. The company has a long history of bad practices and mediocre earnings. I would suggest you to conduct a thorough due diligence before deploying your capital. The short-term price action is merely caused by the bonus issue proposal.

What a happy day. Since I stopped chasing after hot stocks, I just regained all the money lost in gloves and penny stocks. Tech up, telco up, O&G up, value up, blue chip up. Go go go KLCI back to 1800

Deleted

This post has been edited by chromatino_hex: Dec 15 2020, 10:38 AM

KLCI 1750 before Chinese New Year

Come on la. We need KLCI to break new high to impress foreign investor hehe

This post has been edited by chromatino_hex: Dec 15 2020, 09:09 PM

Where did Zerosinfinity go? hope he is still alive

Moderna shots cleared (expected news)

https://www.bloomberg.com/news/articles/202...nd=premium-asia

Next week watchlist:

Steel, technology, consumer cyclicals/retail

2020, A Great Year for Big Businesses, Only

https://www.wsj.com/articles/for-many-big-b...8310791?mod=mhp

If you’ve noticed, two Supermax director recently resigned within the same period of time. But that’s just an anecdote and it’s not meant for further speculations. However:

Someone has pointed out earlier that Supermx has the lowest EPS out of the other three companies and we as shareholders are at a disadvantage because we are paying for the capex without getting much in return. According to the report, the company is spending 45M in renewable energy investment and contact lens. As an investor, I do not like this because the renewable energy industry isn’t mature and the market is oversaturated with foreign and local competitors. Some more quantitative analysis includes the company’s OBM generating their highest source of income. But can their profit sustain once demand drops? In my opinion, its likely to be a one-off event since brand loyalty for glove products is non-existent. Numbers, TG has 722 productions lines 38 factories (800+ mid 2021) Supermx 17 factories/plants (5 new plants including Nitrile Manufacturing Plant) TopGlove claims that it’s production lines are working near 100% Effiency but of course this happens well before the quarantine case. Supermx has much lower production capacity at 26.17 billion per annum TopGlove at 90 billion pieces per annum. Supermx said it is going to use its cash in hand to improve Capex to increase production capacity to approx 46 billion per annum which doesn’t really benefit shareholders at all because in the future, the demand for gloves will most likely decrease. Not to mention their diversification plans (solar/contact lens) which require future expenditures. Whereas, TopGlove has a more conservative approach by spending 10 billion for Capex for organic expansion while rewarding stakeholders with share buybacks and dividend.

I’m no medical expert but there exist side effects for most vaccines. Tuberculosis vaccines have side effects including fainting, shortness of breath, skin allergy. With that being said, it’s preposterous to label the various side effects as a failure for the administration of the vaccine.

However, to express my views in the most neutral way possible, Pfizer does not have a clean history. In fact, over the past few decades, the company has faced class-action lawsuits and lawsuits where consumers claimed the big Pharma sold defective drugs. Under False Claims Zack, Pfizer was ordered by the court to pay 2.3 B in restitution for off-label promotions of products including Zyvox/Lyrica. The company also spent money on political lobbying to gain favourable contracts and government approvals. Pfizer is no saint in the pharmaceutical universe and its long term effects should be continuously monitored and observed under stringent measures - according to medical experts.



This post has been edited by chromatino_hex: Dec 19 2020, 11:43 AM

The consensus is that Supermax is too aggressive on its expansion plans and future demands might not justify such expansion in manufacturing capacity. The problem does not seem to lie within concerns regarding the oversupply of gloves but the company’s approach to utilising its retained profits and “making shareholders happy” (which won’t happen anyway because most people buying Supermx is Fast In Fast Out haha)

You still have gloves under your portfolio?

A few days/weeks ago there’s was a news regarding a furniture company having bad living conditions for foreign workers in Muar. I presume it’s Wegman’s worker hostel

This post has been edited by chromatino_hex: Dec 19 2020, 12:20 PM

We hear no news whatsoever except the announcements in the quarterly report which means jack shit. The company isn’t being transparent unlike TopGlove and Hartalega. Notice we already have two directors resigning and the same time. Wonder when we will see more directors and officers retiring.

No, I don’t think they spent any money on renewable energy investments.

This post has been edited by chromatino_hex: Dec 19 2020, 12:19 PM